Your browser doesn't support javascript.
loading
Isolation and Biological Evaluation of Prenylated Flavonoids from Maclura pomifera.
Orazbekov, Yerkebulan; Ibrahim, Mohamed A; Mombekov, Serjan; Srivedavyasasri, Radhakrishnan; Datkhayev, Ubaidilla; Makhatov, Bauyrzhan; Chaurasiya, Narayan D; Tekwani, Babu L; Ross, Samir A.
Affiliation
  • Orazbekov Y; National Center for Natural Products Research, University of Mississippi, University, MS 38677, USA.
  • Ibrahim MA; South-Kazakhstan State Pharmaceutical Academy, Al-Farabi Square, Shymkent 160019, Kazakhstan.
  • Mombekov S; National Center for Natural Products Research, University of Mississippi, University, MS 38677, USA.
  • Srivedavyasasri R; Department of Chemistry of Natural Compounds, National Research Center, Dokki, Cairo 12622, Egypt.
  • Datkhayev U; Kazakh National Medical University, Almaty 050000, Kazakhstan.
  • Makhatov B; National Center for Natural Products Research, University of Mississippi, University, MS 38677, USA.
  • Chaurasiya ND; Kazakh National Medical University, Almaty 050000, Kazakhstan.
  • Tekwani BL; South-Kazakhstan State Pharmaceutical Academy, Al-Farabi Square, Shymkent 160019, Kazakhstan.
  • Ross SA; National Center for Natural Products Research, University of Mississippi, University, MS 38677, USA.
Article in En | MEDLINE | ID: mdl-29552078
ABSTRACT
Phytochemical analysis of the ethanolic extract of Maclura pomifera fruits yielded four new compounds (I-IV) along with eleven known compounds (V-XV). The crude extract exhibited significant activity towards cannabinoid receptors (CB1 103.4% displacement; CB2 68.8% displacement) and possibly allosteric interaction with δ and µ opioid receptors (-49.7 and -53.8% displacement, resp.). Compound I was found to be possibly allosteric for κ and µ opioid receptors (-88.4 and -27.2% displacement, resp.) and showed moderate activity (60.5% displacement) towards CB1 receptor. Compound II exhibited moderate activity towards cannabinoid receptors CB1 and CB2 (47.9 and 42.3% displacement, resp.). The known compounds (V-VIII) exhibited prominent activity towards cannabinoid receptors pomiferin (V) (IC50 of 2.110 and 1.318 µM for CB1 and CB2, resp.), auriculasin (VI) (IC50 of 8.923 µM for CB1), warangalone (VII) (IC50 of 1.670 and 4.438 µM for CB1 and CB2, resp.), and osajin (VIII) (IC50 of 3.859 and 7.646 µM for CB1 and CB2, resp.). The isolated compounds were also tested for inhibition of human monoamine oxidase-A and monoamine oxidase-B enzymes activities, where all the tested compounds showed fewer inhibitory effects on MAO-A compared to MAO-B activities auriculasin (VI) (IC50 of 1.91 and 45.98 µM for MAO-B and MAO-A, resp.).